Feasibility of allogeneic stem cells for heart regeneration

W. Balkan, V. Y. Suncion, K. S. Telukuntla, J. M. Hare

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Stem cell therapy for heart disease is currently one of the most exciting ideas in regenerative medicine, and allogeneic mesenchymal stem cells (MSCs) are emerging as a lead candidate for cell-based therapeutics. These cells promote healing, have an excellent safety record in preclinical and clinical trials, and are readily available in large quantities. However, there is some controversy regarding their interaction with the host immune system. Allogeneic MSCs are currently in clinical trials as a cell therapy for heart disease, including one trial where the efficacy of allogeneic and autologous MSCs is directly compared. This chapter examines the current and future possibilities of using allogeneic MSCs for cardiac regeneration therapy.

Original languageEnglish (US)
Title of host publicationCardiac Regeneration and Repair
PublisherElsevier Ltd.
Pages207-235
Number of pages29
Volume1
ISBN (Print)9780857096586
DOIs
StatePublished - Feb 2014
Externally publishedYes

Fingerprint

Mesenchymal Stromal Cells
Regeneration
Stem Cells
Cell- and Tissue-Based Therapy
Heart Diseases
Clinical Trials
Regenerative Medicine
Immune System
Safety
Therapeutics

Keywords

  • Allogeneic
  • Cardiac
  • Mesenchymal stem cells
  • Myocardial infarction

ASJC Scopus subject areas

  • Medicine(all)
  • Dentistry(all)

Cite this

Balkan, W., Suncion, V. Y., Telukuntla, K. S., & Hare, J. M. (2014). Feasibility of allogeneic stem cells for heart regeneration. In Cardiac Regeneration and Repair (Vol. 1, pp. 207-235). Elsevier Ltd.. https://doi.org/10.1533/9780857096708.2.207

Feasibility of allogeneic stem cells for heart regeneration. / Balkan, W.; Suncion, V. Y.; Telukuntla, K. S.; Hare, J. M.

Cardiac Regeneration and Repair. Vol. 1 Elsevier Ltd., 2014. p. 207-235.

Research output: Chapter in Book/Report/Conference proceedingChapter

Balkan, W, Suncion, VY, Telukuntla, KS & Hare, JM 2014, Feasibility of allogeneic stem cells for heart regeneration. in Cardiac Regeneration and Repair. vol. 1, Elsevier Ltd., pp. 207-235. https://doi.org/10.1533/9780857096708.2.207
Balkan W, Suncion VY, Telukuntla KS, Hare JM. Feasibility of allogeneic stem cells for heart regeneration. In Cardiac Regeneration and Repair. Vol. 1. Elsevier Ltd. 2014. p. 207-235 https://doi.org/10.1533/9780857096708.2.207
Balkan, W. ; Suncion, V. Y. ; Telukuntla, K. S. ; Hare, J. M. / Feasibility of allogeneic stem cells for heart regeneration. Cardiac Regeneration and Repair. Vol. 1 Elsevier Ltd., 2014. pp. 207-235
@inbook{c8db7536b2574f81a94600c3250cfd54,
title = "Feasibility of allogeneic stem cells for heart regeneration",
abstract = "Stem cell therapy for heart disease is currently one of the most exciting ideas in regenerative medicine, and allogeneic mesenchymal stem cells (MSCs) are emerging as a lead candidate for cell-based therapeutics. These cells promote healing, have an excellent safety record in preclinical and clinical trials, and are readily available in large quantities. However, there is some controversy regarding their interaction with the host immune system. Allogeneic MSCs are currently in clinical trials as a cell therapy for heart disease, including one trial where the efficacy of allogeneic and autologous MSCs is directly compared. This chapter examines the current and future possibilities of using allogeneic MSCs for cardiac regeneration therapy.",
keywords = "Allogeneic, Cardiac, Mesenchymal stem cells, Myocardial infarction",
author = "W. Balkan and Suncion, {V. Y.} and Telukuntla, {K. S.} and Hare, {J. M.}",
year = "2014",
month = "2",
doi = "10.1533/9780857096708.2.207",
language = "English (US)",
isbn = "9780857096586",
volume = "1",
pages = "207--235",
booktitle = "Cardiac Regeneration and Repair",
publisher = "Elsevier Ltd.",

}

TY - CHAP

T1 - Feasibility of allogeneic stem cells for heart regeneration

AU - Balkan, W.

AU - Suncion, V. Y.

AU - Telukuntla, K. S.

AU - Hare, J. M.

PY - 2014/2

Y1 - 2014/2

N2 - Stem cell therapy for heart disease is currently one of the most exciting ideas in regenerative medicine, and allogeneic mesenchymal stem cells (MSCs) are emerging as a lead candidate for cell-based therapeutics. These cells promote healing, have an excellent safety record in preclinical and clinical trials, and are readily available in large quantities. However, there is some controversy regarding their interaction with the host immune system. Allogeneic MSCs are currently in clinical trials as a cell therapy for heart disease, including one trial where the efficacy of allogeneic and autologous MSCs is directly compared. This chapter examines the current and future possibilities of using allogeneic MSCs for cardiac regeneration therapy.

AB - Stem cell therapy for heart disease is currently one of the most exciting ideas in regenerative medicine, and allogeneic mesenchymal stem cells (MSCs) are emerging as a lead candidate for cell-based therapeutics. These cells promote healing, have an excellent safety record in preclinical and clinical trials, and are readily available in large quantities. However, there is some controversy regarding their interaction with the host immune system. Allogeneic MSCs are currently in clinical trials as a cell therapy for heart disease, including one trial where the efficacy of allogeneic and autologous MSCs is directly compared. This chapter examines the current and future possibilities of using allogeneic MSCs for cardiac regeneration therapy.

KW - Allogeneic

KW - Cardiac

KW - Mesenchymal stem cells

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=84902568940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902568940&partnerID=8YFLogxK

U2 - 10.1533/9780857096708.2.207

DO - 10.1533/9780857096708.2.207

M3 - Chapter

AN - SCOPUS:84902568940

SN - 9780857096586

VL - 1

SP - 207

EP - 235

BT - Cardiac Regeneration and Repair

PB - Elsevier Ltd.

ER -